Results for this period
Interim period (second quarter)1 January 2026–30 June 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ thousand).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
While the revision of medical service fees reduced monthly medical insurance revenue per user by approximately ¥200,000 in June, organizational development and the strengthening of the sales division progressed smoothly, and performance in April and May substantially exceeded the year-earlier period.
Not applicable.
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026–30 June 2026 |
| Net Sales | ¥7,604 million (YoY +13.6%) |
| Operating profit | ¥539 million (YoY +85.8%) |
| Ordinary income | ¥292 million (YoY +38.4%) |
| Profit attributable to owners of the parent | ¥167 million (YoY +44.7%) |
| Net income per share | ¥19.79 |
| Equity ratio | End of the current fiscal period 19.5 / End of previous period 19.4 |
| Total assets | ¥18,750 million |
| Net assets | ¥3,662 million |
| Cash flows from operating activities | ¥613,205 thousand |
| Cash flows from investing activities | ¥38,972 thousand |
| Cash flows from financing activities | ¥-736,974 thousand |
| Cash and cash equivalents at end of period | ¥1,928,766 thousand |
| Revision to Earnings Forecast | Net Sales Not disclosed → — (withdrawn) / Operating profit Not disclosed → — (withdrawn) / Ordinary income Not disclosed → — (withdrawn) / Net income Not disclosed → — (withdrawn) |
| Annual Dividend Forecast | ¥25 → — (withdrawn) |
| Depreciation and amortization | ¥288,294 thousand |
| Breakdown of extraordinary income (loss) | Current interim period Not disclosed / Previous interim period Extraordinary income Gain on reversal of subscription rights to shares ¥3,705 thousand / Extraordinary loss Not disclosed |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 / Excluded 0 / Name of newly added company Not disclosed / Excluded Company Name Not disclosed |
| Material subsequent events | Not applicable. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Available (for institutional investors and analysts) |
| Issued Shares at Period-End | 8,484,100 Shares |
| Treasury Shares at Period-End | 1,490 Shares |
| Factors Behind Changes in Business Performance | While the revision of medical service fees reduced monthly medical insurance revenue per user by approximately ¥200,000 in June, organizational development and the strengthening of the sales division progressed smoothly, and performance in April and May substantially exceeded the year-earlier period. |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company explained that organizational development carried over from the previous fiscal year and the strengthening of its sales division progressed smoothly in April and May, resulting in performance substantially exceeding the year-earlier period. In June, however, the revision of medical service fees reduced monthly medical insurance revenue per user by approximately ¥200,000, materially affecting revenue and earnings. The company stated that it was difficult to present figures for its full-year earnings forecast and dividend forecast because many factors affecting performance remain uncertain.